Zhongchao Inc. (ZCMD) News
Filter ZCMD News Items
ZCMD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ZCMD News Highlights
- For ZCMD, its 30 day story count is now at 2.
- Over the past 17 days, the trend for ZCMD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest ZCMD News From Around the Web
Below are the latest news stories about ZHONGCHAO INC that investors may wish to consider to help them evaluate ZCMD as an investment opportunity.
Zhongchao First Half 2023 Earnings: US$0.18 loss per share (vs US$0.004 profit in 1H 2022)Zhongchao ( NASDAQ:ZCMD ) First Half 2023 Results Key Financial Results Revenue: US$10.4m (up 42% from 1H 2022). Net... |
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer TreatmentsZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has renewed its service agreement (the "Agreement") with Beijing Public Health Foundation ("BPHF"), a non-profit organization d |
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness DayZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that its Zhongxin platform launched a WeChat mini program of Breast Cancer Follow-up Visit and Health Management Patient Guide (the "Guide") on Breast Cancer Awareness Day. The Guide aims to provide comprehensive reference for breast cancer patients and support their health management and disease recovery t |
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer PatientsZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the introduction of its Patient-Reported Outcome (PRO) -based symptom management model. This model is geared toward aiding the recovery of lung cancer patients and enhancing their life quality. |
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease ManagementZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced it has achieved a milestone of serving over 10,000 breast cancer patients in China with comprehensive disease management services since 2021. By offering disease management services, Zhongchao aims to ensure effective medical treatments while reducing financial hardships and enhance the overall quality of l |
Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer EducationZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that it cooperates with Shanghai Ximalaya Technology Co., Ltd. ("Ximalaya"), a widely popular Chinese online audio sharing platform in China, to launch the first series of audio courses dedicated to cancer education. |
Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and TreatmentZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the launch of the Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment (the "Platform"). This Platform is designed to elevate the clinical decision-making acumen and patient service capabilities of healthcare professionals, thereby delivering optimal solutions for clinical |
Zhongchao Inc. Announces Strategic Cooperation with XimalayaZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Beijing Zhongchao Boya Medical Technology Co., Ltd. ("Boya Medical"), one of the Chinese operating entities of which the Company consolidates the financial results with through certain contractual arrangements, has signed a strategic cooperation agreement with Shanghai Ximalaya Technology Co., Ltd. ("X |
Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in ChinaZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Chongqing Xinjiang Pharmaceutical Co., Ltd. ("Xinjiang Pharmaceutical"), one of the Chinese operating entities of which the Company consolidates the financial results with through certain contractual arrangements, successfully integrated its introduced drug Naiditawei® into the procurement scope of med |
Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' HealthZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has entered into a service agreement (the "Agreement") with Beijing Public Health Foundation ("BPHF"), a non-profit organization |